Nick Kurahashi

Nick is Vice President of the Global CNS Business for Otsuka Pharmaceutical Development & Commercialization, Inc. He is responsible for alliance management with companies that Otsuka has alliances with, as well as development of global clinical and commercialization strategy for pharmaceutical and digital innovation products.

Throughout his tenure at Otsuka, Nick has applied his passion for science and innovation to further the organization’s long-term goals while successfully developing and managing key products. His career at Otsuka began in 1988 as a researcher and organic chemist for psychiatric disorders in the CNS group in Japan and has steadily progressed to the clinical and commercial aspects of the pharmaceutical business, as well as taking on global roles. In 1996, he became the Product Development Coordinator responsible for the development and coordination of the global clinical plan for an antiplatelet agent. Starting in 2000, he was the International Manager of ABILIFY (aripiprazole) at Otsuka America Pharmaceutical, Inc. He managed coordination between the U.S., E.U., Japan, and Asia, as well as allied companies. By 2003, he became the ABILIFY Product Marketing Manager, leading the brand in Japan, until beginning his current role in 2011.